NCT01519141View on ClinicalTrials.gov

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

CompletedOBSERVATIONAL
Enrollment

579

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Atherosclerosis
Trial Locations (1)

94110

University of California San Francisco, San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER

NCT01519141 - Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection | Biotech Hunter | Biotech Hunter